[D-Ala1] Peptide T

<strong>[D-Ala1] Peptide T</strong>_x000D_ <strong>Catalog number:</strong> B2019217_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -80°C_x000D_ <strong>Keywords:</strong> DAPTA | Adaptavir | 106362-34-9 | (D-Ala1)-peptide T amide | D-Ala-peptide T-amide | RAP101 | L-Threoninamide, D-alanyl-L-seryl-L-threonyl-L-threonyl-L-threonyl-L-asparaginyl-L-tyrosyl- | J208V4ZMP2 | D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 | (2S)-N-[(2S)-1-[[(2S,3R)-1-amino_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Zhao Y, Pang B, Luehmann H, Detering L, Yang X, Sultan D, Harpstrite S, Sharma V, Cutler CS, Xia Y, Liu Y. Gold Nanoparticles Doped with (199) Au Atoms and Their Use for Targeted Cancer Imaging by SPECT Adv Healthc Mater. 2016 Apr 20;5(8):928-35._x000D_ 2: Pang B, Zhao Y, Luehmann H, Yang X, Detering L, You M, Zhang C, Zhang L, Li ZY, Ren Q, Liu Y, Xia Y. ⁶⁴Cu-Doped PdCu@Au Tripods: A Multifunctional Nanomaterial for Positron Emission Tomography and Image-Guided Photothermal Cancer Treatment ACS Nano. 2016 Mar 22;10(3):3121-31._x000D_ 3: Luehmann HP, Pressly ED, Detering L, Wang C, Pierce R, Woodard PK, Gropler RJ, Hawker CJ, Liu Y. PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle J Nucl Med. 2014 Apr;55(4):629-34._x000D_ 4: Su SF, Amidon GL. Investigation into the intestinal metabolism of [D-Ala1] peptide T amide: implication for oral drug delivery Biochim Biophys Acta. 1995 Aug 17;1245(1):62-8._x000D_ 5: Barrera CM, Kastin AJ, Banks WA. D-[Ala1]-peptide T-amide is transported from blood to brain by a saturable system Brain Res Bull. 1987 Dec;19(6):629-33._x000D_ 6: Liapi C, Takahashi N, Raynaud F, Evain-Brion D, Anderson WB. Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts J Invest Dermatol. 1998 Apr;110(4):332-7._x000D_ 7: Knight M, Mack GD, Perkins R, Burke TR Jr. Reversed-phase preparative chromatography of [D-Ala1]-peptide T amide J Chromatogr. 1988 Jul 1;444:345-8._x000D_ 8: Walczak M, Imielska D, Maćkiewicz Z, Kupryszewski G, Dzierzanowska-Madalińska D, Madaliński K. The influence of D-Ala1-peptide_T amide, an analogue of HIV glycoprotein 120 fragment, on the CD4--anti CD4 lymphocyte interaction Arch Immunol Ther Exp (Warsz). 1991;39(1-2):27-31._x000D_ 9: Goodkin K, Vitiello B, Lyman WD, Asthana D, Atkinson JH, Heseltine PN, Molina R, Zheng W, Khamis I, Wilkie FL, Shapshak P. Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide_T-amide for HIV-1-associated cognitive-motor impairment J Neurovirol. 2006 Jun;12(3):178-89._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/1791224">10: Farber EM, Cohen EN, Trozak DJ, Wilkinson DI. Peptide T improves psoriasis when infused into lesions in nanogram amounts J Am Acad Dermatol. 1991 Oct;25(4):658-64. </a>_x000D_ _x000D_ <strong>Products Related to [D-Ala1] Peptide T can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>